Captor Therapeutics SA
CTX
Company Profile
Business description
Captor Therapeutics SA is a biopharmaceutical company. It is focused on development of protein degradation drugs for cancer and autoimmune diseases, which have limited or no known treatment options.
Contact
ul. Dunska 11
Wroclaw54-427
POLT: +48 537869089
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2026
Employees
91
Stocks News & Analysis
stocks
The best way to get rich and retire early
This goes through the different options including shares, property and business ownership and declares a winner, as well as outlining the mindset needed to earn enough to never have to work again.
stocks
Investors overly negative on cheap ASX share
We cut our fair value by 26% but the market has overreacted.
stocks
Overvalued US AI play reports earnings
Strong earnings with high projected growth but price is too rich.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,036.60 | 29.50 | 0.33% |
| CAC 40 | 8,177.58 | 28.08 | 0.34% |
| DAX 40 | 24,577.51 | 87.10 | 0.36% |
| Dow JONES (US) | 48,063.29 | 303.77 | -0.63% |
| FTSE 100 | 9,995.59 | 64.21 | 0.65% |
| HKSE | 26,338.47 | 707.93 | 2.76% |
| NASDAQ | 23,241.99 | 177.09 | -0.76% |
| Nikkei 225 | 50,339.48 | 187.44 | -0.37% |
| NZX 50 Index | 13,548.42 | 0.29 | 0.00% |
| S&P 500 | 6,845.50 | 50.74 | -0.74% |
| S&P/ASX 200 | 8,727.80 | 27.10 | 0.31% |
| SSE Composite Index | 3,968.84 | 3.72 | 0.09% |